Affiliation:
1. Department of Pathobiology, University of Washington, Seattle 98195.
Abstract
The in vitro susceptibilities of eight Chlamydia sp. strain TWAR isolates were tested against tetracycline, erythromycin, penicillin, ampicillin, sulfisoxazole, and a new drug, trospectomycin. The ranges of inhibitory concentrations of these antimicrobial agents, except for sulfonamide, were similar to those for Chlamydia trachomatis. Sulfisoxazole was not inhibitory at the highest nontoxic concentration tested.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference9 articles.
1. Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization;Campbell L. A., C.-C.;J. Clin. Microbiol.,1987
2. Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR;Chi E. Y., C.-C.;J. Bacteriol.,1987
3. A new Chlamydia psittaci strains called TWAR from acute respiratory tract infections;Grayston J. T., C.-C.;N. Engl. J. Med.,1986
4. Identification of a new group of Chlamydia psittaci strains called TWAR;Kuo C.-C., H.-H.;J. Clin. Microbiol.,1986
5. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture;Kuo C.-C., S.-P.;Antimicrob. Agents Chemother.,1977
Cited by
89 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献